Two Sigma Advisers’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-13,327
Closed -$40K 2852
2021
Q4
$40K Sell
13,327
-29,101
-69% -$109K ﹤0.01% 2490
2021
Q3
$174K Sell
42,428
-95,400
-69% -$405K ﹤0.01% 2271
2021
Q2
$696K Buy
137,828
+56,415
+69% +$342K ﹤0.01% 1789
2021
Q1
$821K Buy
81,413
+72,900
+856% +$868K ﹤0.01% 1756
2020
Q4
$44K Buy
8,513
+7,680
+922% +$40.6K ﹤0.01% 2330
2020
Q3
$4K Buy
+833
New +$5.28K ﹤0.01% 2374

Other funds holding NSPR

Two Sigma Advisers's NSPR Position: Q1 2022 in Review

Two Sigma Advisers sold out of InspireMD (NSPR) in Q1 2022, closing a stake of 13,327 shares — an estimated $40K sold.

Two Sigma Advisers first reported a position in NSPR in Q3 2020 and held it in 6 quarters. The position peaked at $821K in Q1 2021. 19 funds tracked by Wall St. Rank hold NSPR as of Q1 2022.

  • Two Sigma Advisers reported no remaining InspireMD position as of Q1 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 13,327 InspireMD shares in Q1 2022, an estimated $40K.
  • Two Sigma Advisers first reported a position in InspireMD in Q3 2020 and held it in 6 quarters.
  • Two Sigma Advisers's InspireMD position peaked at $821K in Q1 2021.
  • 19 funds tracked by Wall St. Rank held InspireMD as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.